713
Participants
Start Date
August 27, 2018
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
sotorasib
Characterize the pharmacokinetics (PK) of sotorasib following administration as an oral Tablet formulation
Anti PD-1/L1
Administered as an intravenous (IV) infusion
Midazolam
Administered as an oral hydrochloride (HCI) syrup
Semmelweis Egyetem, Budapest
Universitaetsklinikum Allgemeines Krankenhaus Wien, Vienna
Orszagos Koranyi Pulmonologiai Intezet, Budapest
Krankenhaus Nord - Klinik Floridsdorf, Vienna
Hopitaux Universitaires de Geneve, Geneva
Scientia Clinical Research Ltd, Randwick
Tudogyogyintezet Torokbalint, Törökbálint
Universitair Ziekenhuis Antwerpen, Edegem
Szent Borbala Korhaz, Tatabánya
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven
Peter MacCallum Cancer Centre, Parkville
Universitaetsklinikum Krems, Krems
Jessa Ziekenhuis - Campus Virga Jesse, Hasselt
Ziekenhuis Oost-Limburg, Genk
Centre Hospitalier Universitaire de Liege, Liège
Universitaetsspital Basel, Basel
Princess Alexandra Hospital, Woolloongabba
The Queen Elizabeth Hospital, Woodville South
Grand Hopital de Charleroi, Charleroi
Medizinische Universitaet Innsbruck, Innsbruck
Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvár
Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár
Medizinische Universitaet Graz, Graz
Universitaetsspital Zuerich, Zurich
AZ Delta Campus Rumbeke, Roeselare
Universitair Ziekenhuis Gent, Ghent
Laura and Isaac Perlmutter Cancer Center at New York University Langone, New York
Memorial Sloan Kettering Cancer Center, New York
National Cancer Center, Goyang-si Gyeonggi-do
Henry Dunant Hospital Center, Athens
Hopital de la Timone, Marseille
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do
Roswell Park Cancer Institute, Buffalo
University of Pittsburgh Medical Center Cancer Pavillion, Pittsburgh
Metropolitan Hospital, Athens
University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
American Oncology Partners of Maryland, PA, Bethesda
US Oncology Research Investigational Products Center, Fairfax
Virginia Cancer Specialists PC, Fairfax
Blue Ridge Cancer Care, Salem
Duke University Medical Center, Morris Cancer Clinic, Durham
Hospital General Universitario Gregorio Marañon, Madrid
Clinica Universidad de Navarra, Madrid
Fundacion Jimenez Diaz, Madrid
Hospital Universitario Madrid Sanchinarro, Madrid
Gibbs Cancer Center and Research Institute - Spartanburg, Spartanburg
Winship Cancer Institute, Atlanta
Institut Claudius Regaud, Toulouse
University of Florida Health, Gainesville
AdventHealth Orlando Infusion Center, Orlando
Institut Bergonie, Bordeaux
Moffitt Cancer Center, Tampa
Vanderbilt University Ingram Cancer Center, Nashville
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic, Cleveland
Universitätsklinikum Essen, Essen
Hospital General Universitario de Valencia, Valencia
Indiana University, Indianapolis
University of Michigan, Ann Arbor
Henry Ford Health System, Detroit
Universitatsklinikum Koln, Cologne
Theagenion Cancer Hospital, Thessaloniki
Agios Loukas Clinic, Thessaloniki
University Hospital of Heraklion, Heraklion - Crete
Institut Curie, Paris
Texas Oncology - Baylor, Dallas
University of Texas Southwestern Medical Center, Dallas
University of Texas MD Anderson Cancer Center, Houston
Texas Oncology - Austin Central, Austin
Rocky Mountain Cancer Centers, Denver
Sarah Cannon Research Institute at HealthONE, Denver
Klinikum der Universität München Campus Grosshadern, München
Huntsman Cancer Institute, Salt Lake City
University of California Los Angeles, Los Angeles
Sarcoma Oncology Research Center LLC, Santa Monica
City of Hope National Medical Center, Duarte
Centre Hospitalier Intercommunal de Créteil, Créteil
University of California at SF, San Francisco
Gustave Roussy, Villejuif
Seattle Cancer Care Alliance, Seattle
Spitalul Municipal Ploiesti, Ploieşti
Centrul de Oncologie Sf Nectarie SRL, Craiova
SC Oncomed SRL, Timișoara
Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj-Napoca
SC Medisprof SRL, Cluj-Napoca
Centrul de Radioterapie Amethyst Cluj, Cluj-Napoca
Institutul Regional de Oncologie Iasi, Iași
Smilow Cancer Hospital at Yale New Haven, New Haven
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Washington University, St Louis
Institut Jules Bordet, Brussels
Irmandade da Santa Casa de Misericordia de Porto Alegre, Nucleo de Novos Tratamentos em Cancer, Porto Alegre
Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre
Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto
Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo
Oncologia Rede D´Or, São Paulo
Instituto Coi, Rio de Janeiro
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
London Regional Cancer Program, London Health Sciences Centre, London
The Ottawa Hospital Cancer Centre, Ottawa
Princess Margaret Cancer Centre, Toronto
McGill University Health Centre Glen Site, Montreal
Aichi Cancer Center, Nagoya
National Cancer Center Hospital East, Kashiwa-shi
National Hospital Organization Shikoku Cancer Center, Matsuyama
National Hospital Organization Kyushu Cancer Center, Fukuoka
National Hospital Organization Hokkaido Cancer Center, Sapporo
St Marianna University Hospital, Kawasaki-shi
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center, Yokohama
Sendai Kousei Hospital, Sendai
Niigata Cancer Center Hospital, Niigata
Okayama University Hospital, Okayama
Kansai Medical University Hospital, Hirakata-shi
Osaka International Cancer Institute, Osaka
Shizuoka Cancer Center, Sunto-gun
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku
Wakayama Medical University Hospital, Wakayama
Fundacao Champalimaud, Lisbon
Centro Hospitalar Universitario de Lisboa Norte EPE - Hospital Pulido Valente, Lisbon
Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano, Matosinhos Municipality
Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio, Porto
Hospital Cuf porto, Porto
Institutul Oncologic, Prof Dr Alexandru Trestioreanu, Bucharest
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea Seoul St Marys Hospital, Seoul
Hospital Universitari Germans Trias i Pujol, Badalona
Lead Sponsor
Amgen
INDUSTRY